FDA approval for US$1.9B Australian-developed cancer treatment
Posted: 19 September 2023 A cancer drug developed in Australia has received the green light from the US Food and Drug Administration (FDA) as a bone marrow cancer treatment. Momelotinib was invented at Cytopia (ASX: CYT), an Australian…
Neo-Bionica launches onshore critical medical manufacturing process
Posted: 18 September 2023 Advanced MedTech contract manufacturer Neo-Bionica has revealed the expansion of its manufacturing services with the launch of its new hermitization capability – a first for Australian industry. Hermitization is a critical capability in the…
World-first child health study recruits 100,000 participants
Posted: 18 September 2023 A world-first study tracking the health and wellbeing of Victorians, from birth to old age, has reached a recruitment milestone of over 100,000 participants. Murdoch Children’s Research Institute’s Generation Victoria (GenV), one of the world’s largest-ever birth…
Million-dollar US Department of Defense grant for Peter Mac melanoma research
Posted: 18 September 2023 The United States Department of Defense has called on Peter Mac to help in its fight against melanoma, granting a million dollars to researcher Dr Lorey Smith. Melanoma is of particular interest to the…
World first drug to target previously untreatable life-threatening form of ‘bad cholesterol’
Posted: 28 September 2023 A new drug offers a breakthrough world-first treatment for Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack and stroke. High levels of Lipoprotein(a), known as Lp(a) or spoken…
Phase 3 Common Cold Trial Results
Posted: 14 September 2023 Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) announces that trial statisticians have completed their efficacy analysis of the headline results in the Phase 3 trial of Nasodine® Nasal Spray (“Nasodine”) as a treatment for the…
Australian Good Design Awards
Posted: 14 September 2023 The Australian Good Design Awards Ceremony is the ultimate showcase of creativity, innovation and design mastery, bringing together the biggest names in the design world to celebrate the year’s best. With a black-tie atmosphere,…
Rhythm Biosciences Contracts with Nutripath on Automation Agreement
Posted: 14 September 2023 As per 31 July (Appendix 4C), transformative cancer diagnostics technology company, Rhythm Biosciences Ltd (ASX: RHY) (“Rhythm” or the “Company”) is pleased to confirm it has progressed the Company’s objective to automate the ColoSTAT®…
geneType Granted Approval for Pancreatic Cancer, Melanoma, and Atrial Fibrillation in Australia
Posted: 11 September 2023 Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce that the expanded geneType Multi-Risk Test is now available…
New Fund Synthesis Capital to power Australia and the Asia-Pacific’s health ventures
Posted: 11 September 2023 A new pathbreaking fund to drive the growth of Australia’s medtech and deeptech health ventures is now raising. Launched this week at the 10-year celebration of the MedTech Actuator’s pathbreaking Origin program, Synthesis Capital…
BioMedTech Horizons Program
Posted: 11 September 2023 Delivered by MTPConnect, the Australian Government’s $45 million BioMedTech Horizons program (BMTH), is a Medical Research Future Fund (MRFF) initiative to support innovative collaborative health technologies, drive discoveries towards proof-of-concept and commercialisation that address key…
Neo-Bionica Launches Hermitization Capability at Melbourne Manufacturing Headquarters
Posted: 6 September 2023 Neo-Bionica, an advanced MedTech contract manufacturer based in Melbourne, is pleased to announce the expansion of its manufacturing services with the launch of its new hermitization capability. This marks the first time that Australian…
